Yumab GmbH Company Profile, Contacts & Intelligence
Yumab GmbH Overview
YUMAB Company profile The German biotech company YUMAB was founded in 2012 as spin-off the University of Braunschweig. In little more than five years, YUMAB (a phonetic play on “HUMAB”, which stands for “human monoclonal antibody and in which the “Y” symbolizes the well-known antibody structure) has become a global player in human monoclonal antibody (mAb) development, and drives the general trend in the immunotherapy space toward the use of fully human mAbs for therapeutic applications. The YUMAB® antibody platform provides rapid, reliable and robust development of “state-of-the-art” and “next-generation” fully human antibodies. The technologies base on more than 28 years of continuous research and development of our founders, who are well recognized scientific experts in the field of recombinant antibody technologies and who have an outstanding track-record in academic and industrial research. YUMAB provides optimized antibody development solutions for: i) discovery & development of novel, fully human antibodies, ii) antibody engineering & humanization, and iii) personalized & custom libraries Key features of the YUMAB® platform are: i) world’s best, naturally derived, universal, human antibody libraries (>10e11) ii) powerful in vitro selection technologies including on-cells-selection for difficult targets iii) large scale screening platforms iv) comprehensive portfolio of antibody engineering & humanization technologies v) compatibility to all therapeutic antibody formats YUMAB provides fee for service solutions with attractive pricing and flexible license models & options as well as collaborative projects. YUMAB’s research & development unit performs internal pipeline and partnered projects ranging from the development of novel antibody therapeutics to the discovery to novel targets technologies. Our mission is to make the best human antibody technologies available for the early development to accelerate translation of research from bench to bedsite.
- Headquarters
- De
- Website
- yumab.com
- Industry
- Biotechnology Research
- Founded
- 2012
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Yumab GmbH Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Yumab GmbH People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Yumab GmbH Workforce Composition
Seniority breakdown across 13 visible profiles.
Compare Similar Companies to Yumab GmbH
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Rentschler Biopharma | Biotechnology Research | 871 | View company |
| PROGEN | Biotechnology | 47 | View company |
| MOLCURE Inc. | Biotechnology Research | 28 | View company |
| Biofidus AG | Biotechnology Research | 23 | View company |
| BlueCatBio | Biotechnology | 21 | View company |
| CORAT Therapeutics GmbH | Biotechnology Research | 9 | View company |
| Cytion | Biotechnology Research | 8 | View company |
| inscreenex GmbH | Biotechnology | 8 | View company |
| Abcalis GmbH | Biotechnology Research | 7 | View company |
| !LEVA Sciences GmbH | Business Consulting And Services | 2 | View company |